These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15699272)

  • 1. Tamoxifen: preventing breast cancer and placing the risk of deep vein thrombosis in perspective.
    Goldhaber SZ
    Circulation; 2005 Feb; 111(5):539-41. PubMed ID: 15699272
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.
    Decensi A; Maisonneuve P; Rotmensz N; Bettega D; Costa A; Sacchini V; Salvioni A; Travaglini R; Oliviero P; D'Aiuto G; Gulisano M; Gucciardo G; del Turco MR; Pizzichetta MA; Conforti S; Bonanni B; Boyle P; Veronesi U;
    Circulation; 2005 Feb; 111(5):650-6. PubMed ID: 15699284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolic disease and stroke in women taking tamoxifen for breast cancer chemoprevention.
    Isaacs C
    Clin Adv Hematol Oncol; 2005 Dec; 3(12):913-4. PubMed ID: 16555431
    [No Abstract]   [Full Text] [Related]  

  • 4. Raloxifene works as well as tamoxifen in preventing invasive breast cancer.
    Mayo Clin Womens Healthsource; 2006 Oct; 10(10):3. PubMed ID: 16977270
    [No Abstract]   [Full Text] [Related]  

  • 5. Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.
    Harv Womens Health Watch; 2002 Oct; 10(2):1-2. PubMed ID: 12393316
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
    Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N
    J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.
    Gail MH; Costantino JP; Bryant J; Croyle R; Freedman L; Helzlsouer K; Vogel V
    J Natl Cancer Inst; 1999 Nov; 91(21):1829-46. PubMed ID: 10547390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemoprevention of breast cancer. Clinical trials in pharmacological prevention].
    Ricart JJ
    Medicina (B Aires); 2004; 64(1):66-72. PubMed ID: 15034961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen for breast cancer prevention: safety warning.
    Wooltorton E
    CMAJ; 2002 Aug; 167(4):378-9. PubMed ID: 12197698
    [No Abstract]   [Full Text] [Related]  

  • 10. Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer.
    Duggan C; Marriott K; Edwards R; Cuzick J
    J Clin Oncol; 2003 Oct; 21(19):3588-93. PubMed ID: 14512389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of breast cancer: recommendations and rationale.
    Berg AO;
    Am J Nurs; 2003 May; 103(5):107, 109, 111, 113. PubMed ID: 12759615
    [No Abstract]   [Full Text] [Related]  

  • 12. Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.
    Ganz PA; Land SR
    Menopause; 2008; 15(4 Suppl):797-803. PubMed ID: 18596601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen and raloxifene may benefit women at high risk for breast cancer.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Jul; 13(14):1-2, 5. PubMed ID: 12518771
    [No Abstract]   [Full Text] [Related]  

  • 14. Medications for Primary Prevention of Breast Cancer.
    Shieh Y; Tice JA
    JAMA; 2020 Jul; 324(3):291-292. PubMed ID: 32692377
    [No Abstract]   [Full Text] [Related]  

  • 15. Experts hopeful about designer estrogens. For some women, selective estrogen receptor modulators (SERMs) help prevent breast cancer.
    Runowicz CD
    Health News; 2003 Apr; 9(4):1-2. PubMed ID: 12710388
    [No Abstract]   [Full Text] [Related]  

  • 16. Tamoxifen for the prevention of breast cancer in high-risk women.
    Sweeney FW; Newton WP
    J Fam Pract; 1999 Feb; 48(2):90-1. PubMed ID: 10037532
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemoprevention of breast cancer: recommendations and rationale.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2002 Jul; 137(1):56-8. PubMed ID: 12093249
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone builder vs. breast cancer.
    Johns Hopkins Med Lett Health After 50; 2007 Jan; 18(11):1-2. PubMed ID: 17323491
    [No Abstract]   [Full Text] [Related]  

  • 19. Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention.
    Goldenberg VK; Seewaldt VL; Scott V; Bean GR; Broadwater G; Fabian C; Kimler B; Zalles C; Lipkus IM
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1032-4. PubMed ID: 17507634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Another view of tamoxifen.
    Napoli M
    Am J Nurs; 2001 Apr; 101(4):33. PubMed ID: 11301681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.